Overview

Child and Adolescent Anxiety Disorders (CAMS)

Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
This randomized, controlled trial compared the efficacy of the medication sertraline (Zoloft®), cognitive-behavioral therapy, the combination of these treatments, and placebo for youth with anxiety disorders.
Phase:
Phase 3
Details
Lead Sponsor:
Johns Hopkins University
National Institute of Mental Health (NIMH)
Collaborator:
National Institute of Mental Health (NIMH)
Treatments:
Sertraline